Source:http://linkedlifedata.com/resource/pubmed/id/12926098
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-8-20
|
pubmed:abstractText |
We investigated the sub-clinical lung injury in patients with breast cancer after chemotherapy by technetium-99m hexamethylpropylene amine oxime (Tc-99m HMPAO) lung scan. Fifty patients who underwent surgical resection for breast cancers were divided into two groups, those who received a combination of adjuvant chemotherapy and those who did not. Group 1 consisted of 25 patients who received adjuvant chemotherapy and group 2 consisted of 25 patients who did not receive adjuvant chemotherapy. Tc-99m HMPAO lung scan was performed in each patient and the degree of pulmonary vascular endothelium damage was represented as lung/liver uptake ratios (L/L ratio). None of the 50 patients had positive plain chest radiograph (CXR) and pulmonary function test (PFT) findings. The results showed a significantly higher L/L ratio in the group 1 patients (0.57 +/- 0.13) than in the group 2 patients (0.32 +/- 0.05). We conclude that chemotherapeutic drugs may result in pulmonary vascular endothelium damage and that Tc-99m HMPAO lung scan has the potential to be a sensitive, objective and non-invasive method to detect sub-clinical lung injury of patients with breast cancers after chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3505-7
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:12926098-Adult,
pubmed-meshheading:12926098-Aged,
pubmed-meshheading:12926098-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12926098-Breast Neoplasms,
pubmed-meshheading:12926098-Chemotherapy, Adjuvant,
pubmed-meshheading:12926098-Endothelium, Vascular,
pubmed-meshheading:12926098-Female,
pubmed-meshheading:12926098-Humans,
pubmed-meshheading:12926098-Liver,
pubmed-meshheading:12926098-Lung,
pubmed-meshheading:12926098-Lung Diseases,
pubmed-meshheading:12926098-Middle Aged,
pubmed-meshheading:12926098-Radiopharmaceuticals,
pubmed-meshheading:12926098-Technetium Tc 99m Exametazime
|
pubmed:articleTitle |
Usefulness of technetium-99m hexamethylpropylene amine oxime lung scan to detect sub-clinical lung injury of patients with breast cancer after chemotherapy.
|
pubmed:affiliation |
Department of Nuclear Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|